Dr. Moshe Yair Levy
Claim this profileTexas Oncology - Sammons
Area of expertise
Chronic Illness
Moshe Yair Levy has run 2 trials for Chronic Illness. Some of their research focus areas include:
Chronic Myelogenous Leukemia
Moshe Yair Levy has run 2 trials for Chronic Myelogenous Leukemia. Some of their research focus areas include:
Affiliated Hospitals
Texas Oncology - Sammons
Baylor Scott & White Health
Clinical Trials Moshe Yair Levy is currently running
Tagraxofusp + Venetoclax + Azacitidine
for Acute Myeloid Leukemia
This study will be divided into 2 parts (Part 1 and Part 2). Part 1 will evaluate 2 doses of tagraxofusp (9 and 12 micrograms/kilogram/day \[μg/kg/day\]), used in combination with venetoclax and azacitidine, to determine the dose for Part 2. This determined dose, in combination with venetoclax and azacitidine, will then be further evaluated in Part 2 in 2 cohorts (TP53 mutated and TP53 wild type). Both parts will be conducted in participants with previously untreated CD123+ AML who are ineligible for intensive chemotherapy.
Recruiting
1 award
Phase 2
10 criteria
Selinexor + R-GDP
for Lymphoma
The purpose of this Phase 2/3 study is to evaluate efficacy and safety of the combination of selinexor and R-GDP (SR-GDP) in patients with RR DLBCL who are not intended to receive hematopoetic stem cell transplantation (HSCT) or chimeric antigen receptor T cell (CAR-T) therapy. This study consists of 3 arms each in Phase 2 and 3. Phase 2 portion of the study will assess the two doses of selinexor (40 milligram \[mg\] or 60 mg) in combination with R-GDP, for up to 6 cycles (21-day per cycle), followed by 60 mg selinexor single agent continuous therapy for those who have reached a partial or complete response. Phase 3 portion of the study will evaluate the selected dose of SR-GDP (identified in Phase 2) versus standard R-GDP + matching placebo, for up to 6 cycles (21-day per cycle), followed by placebo or 60 mg selinexor single agent continuous therapy for those who have reached partial or complete response.
Recruiting
0 awards
Phase 2 & 3
9 criteria
More about Moshe Yair Levy
Clinical Trial Related
3 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Moshe Yair Levy has experience with
- Placebo
- Ianalumab
- Dexamethasone
- Cisplatin
- Placebo Matching For Selinexor (continuous Therapy)
- Rituximab
Breakdown of trials Moshe Yair Levy has run
Chronic Myelogenous Leukemia
Thrombocytopenic Purpura
Diffuse Large B-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Moshe Yair Levy specialize in?
Moshe Yair Levy focuses on Chronic Illness and Chronic Myelogenous Leukemia. In particular, much of their work with Chronic Illness has involved T315I negative patients, or patients who are BCR-ABL1 positive.
Is Moshe Yair Levy currently recruiting for clinical trials?
Yes, Moshe Yair Levy is currently recruiting for 2 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that Moshe Yair Levy has studied deeply?
Yes, Moshe Yair Levy has studied treatments such as Placebo, Ianalumab, Dexamethasone.
What is the best way to schedule an appointment with Moshe Yair Levy?
Apply for one of the trials that Moshe Yair Levy is conducting.
What is the office address of Moshe Yair Levy?
The office of Moshe Yair Levy is located at: Texas Oncology - Sammons, Dallas, Texas 75246 United States. This is the address for their practice at the Texas Oncology - Sammons.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.